First-Line Therapy in T2D: Has Metformin Been'Dethroned'? First-Line Therapy in T2D: Has Metformin Been'Dethroned'?
Joshua Neumiller, PharmD and Radica Alicic, MD, review the changing landscape in first-line therapy medications for type 2 diabetes.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 15, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Myoinositol With Metformin vs Metformin Monotherapy in PCOS Myoinositol With Metformin vs Metformin Monotherapy in PCOS
An RCT looked at the effects of metformin alone or combined with myoinositol in the treatment of PCOS. How do they compare?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Could Metformin Help Seniors Bounce Back After Surgery?
FRIDAY, July 28, 2023 -- The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests.
Researchers found that metformin -- a drug that has been around for more than a half-century to regulate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 28, 2023 Category: General Medicine Source Type: news
Akums gets DCGI nod for triple combination diabetes medication
Akums Drugs and Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) for a triple combination diabetes medication. The drug combines Sitagliptin 100, Pioglitazone 15, and Metformin 1000/500 to provide better treatment without the need for multiple drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2023 Category: Pharmaceuticals Source Type: news
Debate: Initial Combination Therapy for Type 2 Diabetes? Debate: Initial Combination Therapy for Type 2 Diabetes?
Two diabetes research giants, Ralph DeFronzo, MD, and David Nathan, MD, faced off on whether to use initial combination therapy versus starting with metformin and adding more medications sequentially.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - July 13, 2023 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
FDA OKs Empagliflozin for Children With Type 2 Diabetes FDA OKs Empagliflozin for Children With Type 2 Diabetes
Both Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin) were approved for children aged 10 years and older.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 21, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetes
(MedPage Today) -- Two empagliflozin-containing treatments were FDA approved for pediatric type 2 diabetes, the agency announced on Tuesday.
Once-daily empagliflozin (Jardiance) and empagliflozin/metformin hydrochloride (Synjardy) are now indicated... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 21, 2023 Category: American Health Source Type: news
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
June 20, 2023 -- Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 20, 2023 Category: Drugs & Pharmacology Source Type: news
Obesity Changes Brain Forever? More Metformin/Long COVID Data; Ro Stops Wegovy Ads
(MedPage Today) -- Obesity-related brain changes may not be reversible, a small study suggested. (Nature Metabolism)
Nearly a quarter of adults with thyroid nodules also have diabetes, according to a study of nearly 400 patients. (Journal of Clinical... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 13, 2023 Category: Endocrinology Source Type: news
Metformin, SGLT2is Link With Longer T2D Survival Metformin, SGLT2is Link With Longer T2D Survival
Treatment with metformin or an agent from the SGLT2 inhibitor class linked with significantly better survival in people with type 2 diabetes in UK Biobank data.First Look (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - June 12, 2023 Category: Respiratory Medicine Tags: Diabetes & Endocrinology News Source Type: news
Outpatient Metformin Treatment Reduces Incidence of Long COVID
MONDAY, June 12, 2023 -- Outpatient treatment with metformin reduces the incidence of long COVID, especially when started within three days of symptom onset, according to a study published online June 8 in The Lancet Infectious Diseases.
Carolyn T.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 12, 2023 Category: Pharmaceuticals Source Type: news
Study: Metformin Associated With 41% Decrease In Long Covid, Here Are The Caveats
6 ยท3% of those who had taken metformin while infected with the SARS-CoV-2 ended up getting diagnosed with long Covid versus 10.4% of those who had received placebo only. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 11, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
Diabetes Med Metformin Might Help Prevent Long COVID
FRIDAY, June 9, 2023 -- A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows.
Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2023 Category: General Medicine Source Type: news
Study shows metformin lowers the risk of getting long COVID
In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.
The study, called COVID-OUT, investigated if early outpatient COVID-19 treatment with metformin, ivermectin or fluvoxamine could prevent long COVID. Long COVID is a chronic illness that can affect up to 10% of people who have had COVID-19. (Source: World Pharma News)
Source: World Pharma News - June 9, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Diabetes drug may be the pill for long Covid
Taking the diabetes drug metformin within three days of testing positive for Covid-19 may reduce the risk of developing long Covid by 40%, according to a study. The US trial, reported in the Lancet, involved 1,126 overweight and obese patients, 35 of whom were diagnosed with enduring symptoms after taking metformin versus 58 on a placebo. The study did not assess the impact of the drug on those already suffering from long Covid. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 9, 2023 Category: Pharmaceuticals Source Type: news
